Director, Clinical Affairs
Noctrix Health
Director, Clinical Affairs
Noctrix Health
Prescription wearable neuromodulation for RLS.
Noctrix Health is redefining the treatment of chronic neurological disorders with clinically validated therapeutic wearables. Our team of medical device specialists, neuroscientists, and consumer electronics engineers is dedicated to delivering prescription-grade therapy with an outstanding user experience. We have pioneered the world’s first drug-free wearable therapy, clinically proven to alleviate symptoms in adults with drug-resistant Restless Legs Syndrome (RLS). Join us in transforming healthcare, improving lives, and driving meaningful change through innovative medical technology.
We are seeking an experienced and strategic Director, Clinical Affairs to lead the planning, execution, and oversight of clinical studies supporting the development, regulatory approval, reimbursement, and commercialization of Noctrix Health’s medical devices. This leader will be accountable for the successful delivery of clinical programs, ensuring studies are executed efficiently, compliantly, on schedule, and within budget while generating high-quality clinical evidence that supports regulatory and business objectives.
The Director, Clinical Affairs will serve as a key cross-functional leader and liaison among Clinical Affairs, Clinical Research, Regulatory Affairs, Quality, Product Development, and external partners. This individual will provide leadership across clinical operations, including sponsor oversight, site management, CRO and vendor management, clinical data quality, study execution, and evidence generation.
This position reports to the Senior Vice President, Clinical & Regulatory Affairs.
This is a full-time, hybrid position that is located at our Pleasanton headquarters.
Responsibilities:
Requirements:
Preferred Qualifications:
Compensation:
Prescription wearable neuromodulation for RLS.
Noctrix Health develops a prescription wearable that treats restless legs syndrome through non-pharmacologic neuromodulation. Its NTX100 TOMAC System (Nidra) uses leg bands to stimulate the peroneal nerves at night, producing gentle muscle activation to suppress RLS sensations and improve sleep. It differentiates itself with a clinically validated, prescription-based approach backed by an FDA De Novo clearance after a Breakthrough designation, plus roots in Stanford Biodesign. The goal is to make wearable therapeutics a standard, non-drug option for patients who do not respond to or cannot tolerate medications.
Explore more opportunities at Noctrix Health